Back to Search
Start Over
Additional file 3 of A multi-center, single-arm, phase II study of anlotinib plus paclitaxel and cisplatin as the first-line therapy of recurrent/advanced esophageal squamous cell carcinoma
- Publication Year :
- 2023
- Publisher :
- figshare, 2023.
-
Abstract
- Additional file 3: Table S3. Detailed dose titration and delayed dose criteria of anlotinib
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....66176acc4de9837bb59cd1709de9f0b0
- Full Text :
- https://doi.org/10.6084/m9.figshare.22615979